IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Today’s Receipts
Public-record receiptD-FLSource pending

Jared Moskowitz disclosed BUY $GILD

Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.

Trade range
$1K – $15K
Filed
2026-06-22
Trade date
2026-05-06
Disclosure lag
47 days after trade

Why this receipt matters

A quick read before you share it.

These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.

Source pending
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 47 days after the trade date, beyond the standard 45-day STOCK Act window.
3The disclosed range is $1K – $15K, which is the public reporting band rather than an exact profit or loss figure.
42 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Jared Moskowitz, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 15 lobbying filings.
MethodologyData sourcesReport a correctionDownload CSV rowDownload source packet

Source

source pending
Source: indexed congressional disclosure; official source link pending · filed 2026-06-22 · disclosed 47d after transaction

Market context

Gilead Sciences Inc.

Sector: Healthcare

Post-trade move: -8.3%

Vs SPY: -8.5%

Factual flags

  • Filed after the standard 45-day STOCK Act window.
  • 15 lobbying filings linked to this ticker.
  • 2 nearby same-ticker disclosures in the surrounding 30-day window.
  • Filed 47 days after transaction (STOCK Act limit: 45)

Member trail

Jared Moskowitz

U.S. House · FL-23

House Committee on the JudiciaryHouse Committee on Foreign AffairsHouse Select Subcommittee to Investigate the Remaining Questions Surrounding January 62021

Ticker trail

$GILD

Gilead Sciences Inc.

Follow this ticker

Alert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.